Toxicology in the 21st century--working our way towards a visionary reality.

In November 2009 the In Vitro Testing Industrial Platform (IVTIP) organized a meeting entitled 'Toxicology in the 21st century--working our way towards a visionary reality'. Participating delegates included scientists, key opinion leaders, developers and users of 3Rs-related tests and testing strategies. This paper summarizes the discussions with respect to the conditions required to move the vision towards an applicable reality. It should not be considered as a comprehensive review of technologies that could be relevant for moving the in vitro testing and risk assessment field forward. Overall, the U.S. National Research Council (NRC) vision and strategy for toxicity testing in the 21st century was unanimously considered as the right approach to enable future toxicity testing without animal experimentation. Many elements of this vision were identified in the European initiatives aimed at the development of non-animal based methods. However, the need for concerted actions moving the current state-of-the-art towards a thorough, reliable and systematic approach to future toxicity testing was made evident by the discussions. Among the difficulties and hurdles on the way forward, the lack of physiologically relevant, metabolic competent and robust in vivo, ex vivo and in vitro models of both healthy and diseased people was frequently mentioned. In addition, there was a call for immediate implementation of emerging technologies and paradigms considered to be essential for transferring the vision into the reality of a toxicity-testing system assessing biologically significant perturbations in key pathways which are relevant for human biology. While the unique strengths of each of the available and emerging technologies was recognized, integration of available data and emerging technologies to integrated testing strategies (ITS) was highlighted as the preferred way forward. Method harmonization and standardization, as well as procedures and guidelines for putting together ITS, were urgently requested in order to facilitate proper implementation and acceptance. There was an urgent call for better coordination of the efforts that are ongoing or initiated in the 3Rs arena at national and international level. Education, training, communication and dissemination were addressed. It was recognised that the EPAA, through its 'Platform for Communication and Dissemination', has a very important and central role in this area.

[1]  J. Voynow,et al.  Respiratory carcinoma cell lines. MUC genes and glycoconjugates. , 1999, American journal of respiratory cell and molecular biology.

[2]  N. Krug,et al.  Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  J. Valentin Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[4]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[5]  Allan Peter Davis,et al.  Genetic and environmental pathways to complex diseases , 2009, BMC Systems Biology.

[6]  James Reason,et al.  Human Error , 1990 .

[7]  Karen Lowrie,et al.  Toxicity testing in the 21st century. , 2009, Risk analysis : an official publication of the Society for Risk Analysis.

[8]  Simon Thomas,et al.  Physiologically-based Simulation Modelling for the Reduction of Animal Use in the Discovery of Novel Pharmaceuticals , 2009, Alternatives to laboratory animals : ATLA.

[9]  T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[10]  Winton,et al.  Cell lines of pulmonary and non‐pulmonary origin as tools to study the effects of house dust mite proteinases on the regulation of epithelial permeability , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Marcello Lotti,et al.  Toxicology: A risky business , 2002, Nature.

[12]  E. Dougherty,et al.  Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. , 2004, Environmental health perspectives.

[13]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[14]  Julian L Griffin,et al.  Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. , 2003, Current opinion in chemical biology.

[15]  Raffaella Corvi,et al.  The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach , 2006, Alternatives to laboratory animals : ATLA.

[16]  J. Kleinjans,et al.  Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. , 2004, Carcinogenesis.

[17]  D. Blacker Food for thought. , 2013, JAMA neurology.

[18]  Kristina Luthman,et al.  Allergic contact dermatitis--formation, structural requirements, and reactivity of skin sensitizers. , 2008, Chemical research in toxicology.

[19]  Andrew Worth,et al.  Overcoming Barriers to Validation of Non-animal Partial Replacement Methods/Integrated Testing Strategies: The Report of an EPAA–ECVAM Workshop , 2009, Alternatives to laboratory animals : ATLA.

[20]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[21]  Carl Westmoreland,et al.  A future approach to measuring relative skin sensitising potency: a proposal , 2006, Journal of applied toxicology : JAT.

[22]  Johannes J M van de Sandt,et al.  Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. , 2006, Toxicology letters.

[23]  Michael Balls,et al.  Replacement Alternatives in Teaching. Progress in the reduction, refinement and replacement of Animal Experimentation , 1999 .

[24]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[25]  Thomas Hartung,et al.  Food for thought... on cell culture. , 2007, ALTEX.